Detalles de la búsqueda
1.
Peripheral immune cell profiling of double-hit lymphoma by mass cytometry.
BMC Cancer
; 23(1): 184, 2023 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36823603
2.
High efficacy of PD-1 inhibitor after initial failure of PD-L1 inhibitor in Relapsed/Refractory classical Hodgkin Lymphoma.
BMC Cancer
; 22(1): 9, 2022 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34980000
3.
Prophylactic antibiotic treatment with TMP-SMX decreased the incidence of interstitial pneumonia in patients with B-cell lymphoma on chemotherapy.
BMC Cancer
; 20(1): 742, 2020 Aug 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32770971
4.
Long non-coding RNA NEAT1 serves as a novel biomarker for treatment response and survival profiles via microRNA-125a in multiple myeloma.
J Clin Lab Anal
; 34(9): e23399, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32608537
5.
Integration analysis of tumor metagenome and peripheral immunity data of diffuse large-B cell lymphoma.
Front Immunol
; 14: 1146861, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37234150
6.
The Prognostic Utility of 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Analyses of Metabolic Response Rates in Newly Diagnosed Diffuse Large B Cell Lymphoma Patients.
Front Oncol
; 12: 772773, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35677166
7.
Distinct Molecular Subtypes of Diffuse Large B Cell Lymphoma Patients Treated with Rituximab-CHOP Are Associated with Different Clinical Outcomes and Molecular Mechanisms.
Biomed Res Int
; 2021: 5514726, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34250086
8.
Radiosensitizing effect of c-Met kinase inhibitor BPI-9016M in esophageal squamous cell carcinoma cells in vitro and in vivo.
Ann Transl Med
; 9(24): 1799, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35071493
9.
Bruton's tyrosine kinase inhibitors in primary central nervous system lymphoma-evaluation of anti-tumor efficacy and brain distribution.
Transl Cancer Res
; 10(5): 1975-1983, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35116520
10.
Pretreatment systemic inflammation response index (SIRI) is an independent predictor of survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapy: a two-center retrospective study.
Ann Transl Med
; 8(20): 1310, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33209890
11.
A retrospective study of shrinking field radiation therapy during chemoradiotherapy in stage III non-small cell lung cancer.
Oncotarget
; 9(15): 12443-12451, 2018 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-29552324
12.
A Retrospective Comparison of Taxane and Fluorouracil-based Chemoradiotherapy in Patients with Inoperable Esophageal Squamous Cell Carcinoma.
J Cancer
; 7(9): 1066-73, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27326249
13.
Analysis of Clinical and Dosimetric Factors Influencing Radiation-Induced Lung Injury in Patients with Lung Cancer.
J Cancer
; 6(11): 1172-8, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26516366
Resultados
1 -
13
de 13
1
Próxima >
>>